SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir's recent report and forward guidance are sparking heated debate, with some celebrating the company's growth in the AI space while others express concerns about its high valuation. The community is divided between those who see long-term potential and those who anticipate a correction. Discussions also involve CEO Karp's commentary and Michael Burry's short position against the stock.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as investors discuss the potential impact of recent trial results and earnings, with debates focusing on the future of Elevidys and its potential to replace older treatments. The community is weighing positive revenue beats against concerns about trial data and FDA decisions, with some speculating about a potential buyout. Sentiment is mixed, with bulls emphasizing long-term growth potential and bears pointing to regulatory uncertainty and potential market corrections.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels is trending amidst mixed reactions to recent earnings, with community members debating whether a revenue beat and EPS miss present a buying opportunity or a value trap. Discussions also revolve around the potential impact of a possible easing of rare earth export restrictions by China, balanced against the company's strategic position in domestic uranium and rare earth production. Some traders point to substantial call option activity, while others focus on technical indicators and potential government support for the sector.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amid discussions around Q3 earnings, potential short squeeze, and a possible partnership with Novo Nordisk. Community talking points revolve around the company's growth potential, expansion into new markets like comprehensive testing and international, and revenue acceleration, with some expressing concerns around profitability and volatility. Speculation around partnerships and target prices is also contributing to the heightened interest.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending amid discussions about its strategic direction and upcoming R2 vehicle launch. The community is focused on the company's potential to compete in the mass market and address existing quality and service concerns. Some are also considering how recent partnerships and fleet orders might impact the company's growth.

Grab Holdings Ltd. engages in the provision of millions of people each day to access its driver- and merchant-partners to order food or groceries, send packages, hail a ride or taxi, pay for online purchases or access services such as lending, insurance, wealth management and telemedicine, all through a single “everyday everything” app. The firm operates in food deliveries and mobility and by TPV in the e-wallets segment of financial services in Southeast Asia. It operates across the deliveries, mobility and digital financial services sectors in eight countries namely: Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam. The company was founded by Anthony Tan Ping Yeow and Tan Hooi Ling in 2012 and is headquartered in Singapore.

Grab Holdings Limited - Ordinary Shares - Class A

Grab Holdings Limited

Grab Holdings is trending amid discussions about its earnings potential and recent option activity, with call buying suggesting bullish sentiment. Community members are debating the reasons behind the stock's recent movements, the impact of raised guidance, and whether it represents a long-term growth opportunity in the Southeast Asian market. There is also discussion around a settlement for investors and potential inclusion in the S&P 500.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

DASH is trending amid discussions about its potential for a significant price increase, with some community members drawing comparisons to ZEC and speculating on a possible "privacy coins season." Community members highlight DASH's limited supply and potential for high gains, with some suggesting it is undervalued. Conversations also mention its utility in regions with high inflation and its potential for use in decentralized finance.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors discuss a potential offering following recent earnings and a new clinical program, while also considering the impact of a new CFO. The community debates management's spending and strategy, as well as the lawsuit against CMS, with some expressing frustration over the stock's performance despite company progress. Bullish investors focus on revenue growth, potential acquisitions, and positive analyst ratings, while bears cite concerns about dilution and management decisions.

Goodyear Tire & Rubber Co. engages in the development, manufacture, distribution, and sale of tires. It operates through the following geographical segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The Americas segment is involved in the development, manufacture, distribution, and sale of tires and related products and services in North, Central, and South America. The Europe, Middle East, and Africa segment focuses on the development, manufacture, distribution, and sale of tires for automobiles, trucks, buses, aircraft, motorcycles, earthmoving, mining, and industrial equipment throughout Europe, the Middle East, and Africa. The Asia Pacific segment refers to the development, manufacture, distribution, and sales of tires for automobiles, trucks, buses, aircraft, farm, earthmoving, mining, and industrial equipment throughout the Asia Pacific region. The company was founded by Frank A. Seiberling on August 29, 1898 and is headquartered in Akron, OH.

Goodyear Tire & Rubber Co.

Goodyear is trending as investors discuss its recent earnings report, with some highlighting better-than-expected results and others expressing concern about the company's financial health. Community members are debating the company's valuation, turnaround potential, and debt reduction efforts. Several are pointing to the stock being potentially undervalued.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

NUVB is trending due to recent earnings and upcoming catalysts, including late-stage negotiations for a EU partnership deal expected in Q4. The community is actively discussing the company's IBTROZI launch progress, ongoing safusidenib trials, and its potential compared to competitor Nuvalent. Some investors are hoping for a short squeeze, while others are focused on the long-term potential of NUVB's pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


rr88fa

Nhà Cái RR88FA